Regan D P, Escaffi A, Coy J, Kurihara J, Dow S W
Flint Animal Cancer Center, Department of Clinical Sciences, Colorado State University, Fort Collins, CO, USA.
Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO, USA.
Vet Comp Oncol. 2017 Dec;15(4):1309-1322. doi: 10.1111/vco.12272. Epub 2016 Oct 25.
Canine hemangiosarcoma (HSA) is a highly malignant tumour associated with short survival times because of early and widespread metastasis. In humans and rodents, monocytes play key roles in promoting tumour metastasis through stimulating tumour cell extravasation, seeding, growth and angiogenesis. Therefore, we investigated the potential association between monocyte infiltration and tumour metastasis in HSA and other common canine tumours. Immunohistochemistry was used to quantify CD18 monocytes within metastases. We found that HSA metastases had significantly greater numbers of CD18 monocytes compared with metastases from other tumour types. HSA cells were the highest producers of the monocyte chemokine CCL2, and stimulated canine monocyte migration in a CCL2 dependent manner. These results are consistent with the hypothesis that overexpression of CCL2 and recruitment of large numbers of monocytes may explain in part the aggressive metastatic nature of canine HSA. Thus, therapies designed to block monocyte recruitment may be an effective adjuvant strategy for suppressing HSA metastasis in dogs.
犬血管肉瘤(HSA)是一种高度恶性肿瘤,由于早期广泛转移,其生存时间较短。在人类和啮齿动物中,单核细胞通过刺激肿瘤细胞外渗、播种、生长和血管生成,在促进肿瘤转移中发挥关键作用。因此,我们研究了单核细胞浸润与HSA及其他常见犬类肿瘤中肿瘤转移之间的潜在关联。免疫组织化学用于量化转移灶内的CD18单核细胞。我们发现,与其他肿瘤类型的转移灶相比,HSA转移灶中的CD18单核细胞数量显著更多。HSA细胞是单核细胞趋化因子CCL2的最高产生者,并以CCL2依赖的方式刺激犬单核细胞迁移。这些结果与以下假设一致,即CCL2的过度表达和大量单核细胞的募集可能部分解释了犬HSA的侵袭性转移特性。因此,旨在阻断单核细胞募集的疗法可能是抑制犬HSA转移的一种有效辅助策略。